A randomized clinical trial for evaluating effects of activated donor liver mononuclear cells inoculation on liver transplantation recipients with hepatitis C (HCV).
Not Applicable
- Conditions
- iver transplantation recipients with HCV
- Registration Number
- JPRN-UMIN000000538
- Lead Sponsor
- Department of surgery, division of frontier medical science, programs for biomedical research, Graduate school of biomedical sciences, Hiroshima university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Symptomatic infectious disease Fluminant hepatitis ABO incompatible transplantation Retransplantation Decision as ineligible by principal investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5-year survival rate, and SVR
- Secondary Outcome Measures
Name Time Method Adverse events, Postoperative infectious complication rate, Median overall survival